Correlation Between Day One and Phathom Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Day One and Phathom Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Phathom Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Day One Biopharmaceuticals and Phathom Pharmaceuticals, you can compare the effects of market volatilities on Day One and Phathom Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Phathom Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Phathom Pharmaceuticals.

Diversification Opportunities for Day One and Phathom Pharmaceuticals

-0.16

Correlation Coefficient

Day One  Phathom Pharmaceuticals

Good diversification

The 3 months correlation between Day and Phathom is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Phathom Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phathom Pharmaceuticals and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Phathom Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phathom Pharmaceuticals has no effect on the direction of Day One i.e., Day One and Phathom Pharmaceuticals go up and down completely randomly.

Pair Corralation between Day One and Phathom Pharmaceuticals

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the Phathom Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Day One Biopharmaceuticals is 4.12 times less risky than Phathom Pharmaceuticals. The stock trades about -0.03 of its potential returns per unit of risk. The Phathom Pharmaceuticals is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  336.00  in Phathom Pharmaceuticals on May 1, 2025 and sell it today you would earn a total of  526.00  from holding Phathom Pharmaceuticals or generate 156.55% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Day One Biopharmaceuticals  vs.  Phathom Pharmaceuticals

Day One Biopharmaceu

Risk-Adjusted Performance

Very Weak

Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Phathom Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Phathom Pharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Phathom Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Day One and Phathom Pharmaceuticals

The main advantage of trading using opposite Day One and Phathom Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Phathom Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phathom Pharmaceuticals will offset losses from the drop in Phathom Pharmaceuticals' long position.

The idea behind Day One Biopharmaceuticals and Phathom Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.